Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Research and Development

Human HealthOasmia is developing the next generation of drugs with focus on oncology.

Further reading »

About Oasmia

Animal HealthOasmia is a pharmaceutical company in Uppsala, Sweden with one approved product in Russia and one conditionally approved in the USA.

Further reading »

The Share

Latest News

Communiqué from Oasmia’s Annual General Meeting 2016

September 27 2016
Oasmia Pharmaceutical AB (publ.), with VAT no SE556332-667601, held its Annual General Meeting for the fiscal year 2015/2016 on Monday, September 26, 2016, where and the following main resolutions were made. For detailed information about the content of the resolutions, see the complete notice for Annual General Meeting which is available on Oasmia’s website www.oasmia.com, together with the complete proposals for the resolutions below.
Further reading »

Interim report for the period May - July 2016

September 2 2016
Additional market approval for Paclical
Further reading »

Oasmia Pharmaceutical AB Appoints Fredrik Gynnerstedt as Chief Financial Officer

August 31 2016
Further reading »